

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 5.71079227 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 5.63337068 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 5.53260260 |
| 4 | regulation of mononuclear cell migration (GO:0071675) | 5.26142598 |
| 5 | glycolipid catabolic process (GO:0019377) | 5.15958843 |
| 6 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.85596152 |
| 7 | amino sugar catabolic process (GO:0046348) | 4.66769578 |
| 8 | ceramide catabolic process (GO:0046514) | 4.60400559 |
| 9 | N-acetylneuraminate metabolic process (GO:0006054) | 4.16927612 |
| 10 | membrane lipid catabolic process (GO:0046466) | 4.12248585 |
| 11 | T-helper 1 type immune response (GO:0042088) | 4.02733388 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.00844012 |
| 13 | sphingolipid catabolic process (GO:0030149) | 3.89918401 |
| 14 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.88114198 |
| 15 | positive regulation of leukocyte degranulation (GO:0043302) | 3.85702172 |
| 16 | response to thyroid hormone (GO:0097066) | 3.80693634 |
| 17 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.77692617 |
| 18 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.77051321 |
| 19 | regulation of macrophage chemotaxis (GO:0010758) | 3.73285078 |
| 20 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.72884238 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.70030185 |
| 22 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.64954254 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.60440791 |
| 24 | regulation of podosome assembly (GO:0071801) | 3.53474045 |
| 25 | regulation of mast cell degranulation (GO:0043304) | 3.52095153 |
| 26 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.50458483 |
| 27 | positive regulation of mast cell degranulation (GO:0043306) | 3.50458483 |
| 28 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.48508975 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 3.40224206 |
| 30 | positive regulation of mast cell activation (GO:0033005) | 3.38333837 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37945610 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37945610 |
| 33 | positive regulation of heat generation (GO:0031652) | 3.37522987 |
| 34 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.37318383 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.36327934 |
| 36 | monocyte chemotaxis (GO:0002548) | 3.32902483 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.32353455 |
| 38 | L-phenylalanine metabolic process (GO:0006558) | 3.31927946 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.31927946 |
| 40 | myeloid dendritic cell differentiation (GO:0043011) | 3.29604468 |
| 41 | L-phenylalanine catabolic process (GO:0006559) | 3.28598815 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.28598815 |
| 43 | regulation of leukocyte degranulation (GO:0043300) | 3.25319133 |
| 44 | regulation of chemokine biosynthetic process (GO:0045073) | 3.25281780 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23343140 |
| 46 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.22482428 |
| 47 | drug transmembrane transport (GO:0006855) | 3.22388825 |
| 48 | cellular response to arsenic-containing substance (GO:0071243) | 3.22232613 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.19810555 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19551534 |
| 51 | barbed-end actin filament capping (GO:0051016) | 3.17047714 |
| 52 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13729366 |
| 53 | regulation of fever generation (GO:0031620) | 3.12009692 |
| 54 | regulation of monocyte chemotaxis (GO:0090025) | 3.09939016 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09680564 |
| 56 | granulocyte activation (GO:0036230) | 3.09282187 |
| 57 | aromatic amino acid family catabolic process (GO:0009074) | 3.07598312 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06848947 |
| 59 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.06332064 |
| 60 | cysteine metabolic process (GO:0006534) | 3.05075650 |
| 61 | urate metabolic process (GO:0046415) | 3.02388678 |
| 62 | drug transport (GO:0015893) | 3.01362681 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.00810560 |
| 64 | adenosine receptor signaling pathway (GO:0001973) | 2.99196599 |
| 65 | myeloid dendritic cell activation (GO:0001773) | 2.98267200 |
| 66 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.97825358 |
| 67 | aldehyde catabolic process (GO:0046185) | 2.97592125 |
| 68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97328926 |
| 69 | neutrophil activation involved in immune response (GO:0002283) | 2.95196551 |
| 70 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.94967761 |
| 71 | response to acidic pH (GO:0010447) | 2.94332462 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 2.93923220 |
| 73 | indolalkylamine catabolic process (GO:0046218) | 2.93923220 |
| 74 | tryptophan catabolic process (GO:0006569) | 2.93923220 |
| 75 | regulation of vitamin metabolic process (GO:0030656) | 2.93385339 |
| 76 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.92373771 |
| 77 | regulation of superoxide anion generation (GO:0032928) | 2.91842069 |
| 78 | tryptophan metabolic process (GO:0006568) | 2.89366258 |
| 79 | keratan sulfate catabolic process (GO:0042340) | 2.88781366 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.88546398 |
| 81 | macrophage activation (GO:0042116) | 2.88114973 |
| 82 | complement activation, alternative pathway (GO:0006957) | 2.87148708 |
| 83 | valine metabolic process (GO:0006573) | 2.86544027 |
| 84 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.86196660 |
| 85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85281482 |
| 86 | amyloid precursor protein catabolic process (GO:0042987) | 2.85245048 |
| 87 | positive regulation of cholesterol efflux (GO:0010875) | 2.82999486 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.82486750 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81766616 |
| 90 | lytic vacuole organization (GO:0080171) | 2.81702645 |
| 91 | lysosome organization (GO:0007040) | 2.81702645 |
| 92 | peptide catabolic process (GO:0043171) | 2.81633708 |
| 93 | adhesion of symbiont to host (GO:0044406) | 2.81224672 |
| 94 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80936091 |
| 95 | protein carboxylation (GO:0018214) | 2.80896425 |
| 96 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.80896425 |
| 97 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.80537167 |
| 98 | detection of other organism (GO:0098543) | 2.79395797 |
| 99 | macrophage differentiation (GO:0030225) | 2.78980860 |
| 100 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78043541 |
| 101 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.76956808 |
| 102 | phagosome maturation (GO:0090382) | 2.76478141 |
| 103 | glyoxylate metabolic process (GO:0046487) | 2.76305605 |
| 104 | germinal center formation (GO:0002467) | 2.76200957 |
| 105 | glucuronate metabolic process (GO:0019585) | 2.76055966 |
| 106 | uronic acid metabolic process (GO:0006063) | 2.76055966 |
| 107 | positive regulation by symbiont of host defense response (GO:0052509) | 2.74888225 |
| 108 | modulation by symbiont of host defense response (GO:0052031) | 2.74888225 |
| 109 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.74888225 |
| 110 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.74888225 |
| 111 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.74888225 |
| 112 | modulation by symbiont of host immune response (GO:0052553) | 2.74888225 |
| 113 | amino-acid betaine metabolic process (GO:0006577) | 2.74826492 |
| 114 | dendritic cell differentiation (GO:0097028) | 2.74680245 |
| 115 | detection of external biotic stimulus (GO:0098581) | 2.74309352 |
| 116 | regulation of interleukin-12 production (GO:0032655) | 2.74209259 |
| 117 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.74029999 |
| 118 | cellular response to lipopolysaccharide (GO:0071222) | 2.73881246 |
| 119 | myeloid cell activation involved in immune response (GO:0002275) | 2.73274696 |
| 120 | positive regulation of interferon-alpha production (GO:0032727) | 2.72405306 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.71734531 |
| 122 | homocysteine metabolic process (GO:0050667) | 2.71404435 |
| 123 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.69268799 |
| 124 | regulation of cholesterol esterification (GO:0010872) | 2.64887558 |
| 125 | cellular modified amino acid catabolic process (GO:0042219) | 2.58830660 |
| 126 | regulation of cholesterol storage (GO:0010885) | 2.57479011 |
| 127 | alpha-linolenic acid metabolic process (GO:0036109) | 2.57274413 |
| 128 | angiotensin maturation (GO:0002003) | 2.55549953 |
| 129 | regulation of interferon-alpha production (GO:0032647) | 2.54468331 |
| 130 | phospholipid efflux (GO:0033700) | 2.51595655 |
| 131 | flavonoid metabolic process (GO:0009812) | 2.51528400 |
| 132 | carnitine metabolic process (GO:0009437) | 2.50999009 |
| 133 | regulation of triglyceride catabolic process (GO:0010896) | 2.50438849 |
| 134 | kynurenine metabolic process (GO:0070189) | 2.50325030 |
| 135 | short-chain fatty acid metabolic process (GO:0046459) | 2.49644535 |
| 136 | cellular glucuronidation (GO:0052695) | 2.49412696 |
| 137 | plasma lipoprotein particle clearance (GO:0034381) | 2.49283337 |
| 138 | low-density lipoprotein particle clearance (GO:0034383) | 2.48504172 |
| 139 | primary alcohol catabolic process (GO:0034310) | 2.48104114 |
| 140 | ethanol oxidation (GO:0006069) | 2.46877642 |
| 141 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.45074242 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.43493672 |
| 143 | ethanol metabolic process (GO:0006067) | 2.42640577 |
| 144 | fatty acid beta-oxidation (GO:0006635) | 2.42478777 |
| 145 | respiratory burst (GO:0045730) | 2.42461588 |
| 146 | lysine catabolic process (GO:0006554) | 2.42095174 |
| 147 | lysine metabolic process (GO:0006553) | 2.42095174 |
| 148 | urea metabolic process (GO:0019627) | 2.41263625 |
| 149 | urea cycle (GO:0000050) | 2.41263625 |
| 150 | fatty acid oxidation (GO:0019395) | 2.40166651 |
| 151 | bile acid biosynthetic process (GO:0006699) | 2.39360203 |
| 152 | lipid oxidation (GO:0034440) | 2.39326455 |
| 153 | high-density lipoprotein particle remodeling (GO:0034375) | 2.37360251 |
| 154 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.37091223 |
| 155 | toxin transport (GO:1901998) | 2.35768057 |
| 156 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.34669359 |
| 157 | drug catabolic process (GO:0042737) | 2.33371007 |
| 158 | response to peptidoglycan (GO:0032494) | 2.32430769 |
| 159 | virion attachment to host cell (GO:0019062) | 2.32023369 |
| 160 | adhesion of symbiont to host cell (GO:0044650) | 2.32023369 |
| 161 | regulation of protein activation cascade (GO:2000257) | 2.31964669 |
| 162 | reverse cholesterol transport (GO:0043691) | 2.31429058 |
| 163 | regulation of complement activation (GO:0030449) | 2.30874277 |
| 164 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.29861478 |
| 165 | transcytosis (GO:0045056) | 2.29183348 |
| 166 | nitrogen cycle metabolic process (GO:0071941) | 2.28945329 |
| 167 | apoptotic cell clearance (GO:0043277) | 2.28642448 |
| 168 | mannose metabolic process (GO:0006013) | 2.28405055 |
| 169 | plasma lipoprotein particle remodeling (GO:0034369) | 2.27849789 |
| 170 | protein-lipid complex remodeling (GO:0034368) | 2.27849789 |
| 171 | macromolecular complex remodeling (GO:0034367) | 2.27849789 |
| 172 | aromatic amino acid family metabolic process (GO:0009072) | 2.27847236 |
| 173 | bile acid and bile salt transport (GO:0015721) | 2.27124879 |
| 174 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.26669247 |
| 175 | negative regulation of cholesterol transport (GO:0032375) | 2.26389089 |
| 176 | negative regulation of sterol transport (GO:0032372) | 2.26389089 |
| 177 | positive regulation of coagulation (GO:0050820) | 2.26180781 |
| 178 | NADP metabolic process (GO:0006739) | 2.23491789 |
| 179 | response to nitrosative stress (GO:0051409) | 2.22607012 |
| 180 | fatty acid catabolic process (GO:0009062) | 2.22125148 |
| 181 | low-density lipoprotein particle remodeling (GO:0034374) | 2.21925728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.44665277 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.49717997 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.12816943 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.06264329 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.80115279 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.71817435 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.50410238 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15753565 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.10927464 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.79608363 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.72007181 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52556175 |
| 13 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.51508604 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.45110801 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.41944099 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.37295280 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36060189 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31017932 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.30083535 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27890739 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21817211 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20516887 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20411844 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18047272 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.14966230 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10618285 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88063186 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86430171 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.86260850 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80384628 |
| 31 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.66576467 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65407158 |
| 33 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.64156703 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.62623055 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61978389 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61655648 |
| 37 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.59796310 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59675997 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56425249 |
| 40 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.54464225 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51378139 |
| 42 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.48239744 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47358462 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45199156 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44563867 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43320935 |
| 47 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40749133 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40046315 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39546399 |
| 50 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39479331 |
| 51 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36221213 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33364917 |
| 53 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.32420218 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32342381 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32325852 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32018750 |
| 57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.31279931 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30020430 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28806117 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28731670 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28285655 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25999102 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25692705 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25508367 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25503775 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22559250 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22032593 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21795064 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.21751371 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20295541 |
| 71 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.18283697 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17381012 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15630145 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14665986 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12318449 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09796943 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09197306 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09130400 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09012795 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07052154 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06946713 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03807529 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03391921 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03211161 |
| 85 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.02961612 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01706525 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01704125 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01634205 |
| 89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01489120 |
| 90 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01021259 |
| 91 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99571928 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99501339 |
| 93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99316132 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99253239 |
| 95 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99201404 |
| 96 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98853614 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98014106 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97260608 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96803840 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95824124 |
| 101 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95796296 |
| 102 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94816862 |
| 103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94297061 |
| 104 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93897101 |
| 105 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93639788 |
| 106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93503081 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92784693 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92784693 |
| 109 | * MAF_26560356_Chip-Seq_TH1_Human | 0.92569541 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92337779 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91125944 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89926063 |
| 113 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89659054 |
| 114 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89624310 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89250718 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89230405 |
| 117 | * MYB_26560356_Chip-Seq_TH2_Human | 0.88777485 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88774112 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88052599 |
| 120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87489307 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87255497 |
| 122 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86488680 |
| 123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85423461 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84570252 |
| 125 | UTX_26944678_Chip-Seq_JUKART_Human | 0.84198245 |
| 126 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83948296 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83948296 |
| 128 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83349150 |
| 129 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83289459 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83066118 |
| 131 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80922013 |
| 132 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80605879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.78305283 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.68204570 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.02815128 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.64190723 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 2.59969131 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.45542135 |
| 7 | MP0009840_abnormal_foam_cell | 2.43673347 |
| 8 | MP0005365_abnormal_bile_salt | 2.42608255 |
| 9 | MP0003436_decreased_susceptibility_to | 2.34679688 |
| 10 | MP0004510_myositis | 2.33661744 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.31933473 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.26297886 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.12337166 |
| 14 | MP0003724_increased_susceptibility_to | 2.09603988 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 1.97437974 |
| 16 | MP0008438_abnormal_cutaneous_collagen | 1.96681295 |
| 17 | MP0003690_abnormal_glial_cell | 1.95035066 |
| 18 | MP0009785_altered_susceptibility_to | 1.90718144 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.88747021 |
| 20 | MP0005332_abnormal_amino_acid | 1.88161036 |
| 21 | MP0003252_abnormal_bile_duct | 1.87995582 |
| 22 | MP0003195_calcinosis | 1.85766667 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.83603636 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.83432722 |
| 25 | MP0006082_CNS_inflammation | 1.81183311 |
| 26 | MP0003186_abnormal_redox_activity | 1.80411518 |
| 27 | MP0002419_abnormal_innate_immunity | 1.78286860 |
| 28 | MP0009764_decreased_sensitivity_to | 1.75300345 |
| 29 | MP0000685_abnormal_immune_system | 1.72295283 |
| 30 | MP0005025_abnormal_response_to | 1.70516579 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.68119630 |
| 32 | MP0001790_abnormal_immune_system | 1.67949146 |
| 33 | MP0005387_immune_system_phenotype | 1.67949146 |
| 34 | MP0010329_abnormal_lipoprotein_level | 1.65723704 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.60489362 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.56845093 |
| 37 | MP0009278_abnormal_bone_marrow | 1.53678536 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.47908019 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.47898737 |
| 40 | MP0008469_abnormal_protein_level | 1.42559300 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.41243696 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.39528153 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.39528153 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.38796779 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.37527275 |
| 46 | MP0002136_abnormal_kidney_physiology | 1.36937768 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.36908603 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.36361633 |
| 49 | MP0001958_emphysema | 1.35195158 |
| 50 | MP0001756_abnormal_urination | 1.32810167 |
| 51 | MP0004947_skin_inflammation | 1.31247029 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.29405264 |
| 53 | MP0001873_stomach_inflammation | 1.29230397 |
| 54 | MP0005275_abnormal_skin_tensile | 1.29054195 |
| 55 | MP0005083_abnormal_biliary_tract | 1.26475716 |
| 56 | MP0003329_amyloid_beta_deposits | 1.26460198 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.26173510 |
| 58 | MP0003303_peritoneal_inflammation | 1.23651292 |
| 59 | MP0000609_abnormal_liver_physiology | 1.23414731 |
| 60 | MP0000920_abnormal_myelination | 1.23247387 |
| 61 | MP0001800_abnormal_humoral_immune | 1.22816020 |
| 62 | MP0005310_abnormal_salivary_gland | 1.22724117 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.21370426 |
| 64 | MP0002723_abnormal_immune_serum | 1.19300633 |
| 65 | MP0002254_reproductive_system_inflammat | 1.18796166 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.14712001 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.13815472 |
| 68 | MP0001765_abnormal_ion_homeostasis | 1.13813725 |
| 69 | MP0000604_amyloidosis | 1.13805731 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13316351 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.11882229 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.11844832 |
| 73 | MP0005671_abnormal_response_to | 1.10239450 |
| 74 | MP0000343_altered_response_to | 1.08975148 |
| 75 | MP0002006_tumorigenesis | 1.08706135 |
| 76 | MP0002090_abnormal_vision | 1.08294224 |
| 77 | MP0001819_abnormal_immune_cell | 1.06380351 |
| 78 | MP0006054_spinal_hemorrhage | 1.05693899 |
| 79 | MP0002420_abnormal_adaptive_immunity | 1.05020634 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 1.03057931 |
| 81 | MP0003866_abnormal_defecation | 1.02599041 |
| 82 | MP0005165_increased_susceptibility_to | 1.02225377 |
| 83 | MP0002405_respiratory_system_inflammati | 1.01472790 |
| 84 | MP0000716_abnormal_immune_system | 1.00376773 |
| 85 | MP0003828_pulmonary_edema | 1.00257101 |
| 86 | MP0003075_altered_response_to | 1.00138322 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.98752565 |
| 88 | MP0000858_altered_metastatic_potential | 0.98053333 |
| 89 | MP0001853_heart_inflammation | 0.97206509 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.96878712 |
| 91 | MP0004043_abnormal_pH_regulation | 0.94152661 |
| 92 | MP0008260_abnormal_autophagy | 0.92576392 |
| 93 | MP0005166_decreased_susceptibility_to | 0.91865070 |
| 94 | MP0010307_abnormal_tumor_latency | 0.90914592 |
| 95 | MP0001663_abnormal_digestive_system | 0.90870721 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.90604131 |
| 97 | MP0009763_increased_sensitivity_to | 0.90097236 |
| 98 | MP0002933_joint_inflammation | 0.89930614 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.89274596 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.89237901 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.87936637 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.87716339 |
| 103 | MP0001542_abnormal_bone_strength | 0.86408904 |
| 104 | MP0002132_abnormal_respiratory_system | 0.85885595 |
| 105 | MP0002796_impaired_skin_barrier | 0.84982107 |
| 106 | MP0003634_abnormal_glial_cell | 0.84849097 |
| 107 | MP0008004_abnormal_stomach_pH | 0.84423338 |
| 108 | MP0005164_abnormal_response_to | 0.84108658 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.81641951 |
| 110 | MP0000465_gastrointestinal_hemorrhage | 0.80958555 |
| 111 | MP0005408_hypopigmentation | 0.80835378 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.80700003 |
| 113 | MP0001764_abnormal_homeostasis | 0.80610922 |
| 114 | MP0002060_abnormal_skin_morphology | 0.80188244 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.80168239 |
| 116 | MP0005451_abnormal_body_composition | 0.80085522 |
| 117 | MP0003879_abnormal_hair_cell | 0.79807011 |
| 118 | MP0003448_altered_tumor_morphology | 0.79627268 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.79584748 |
| 120 | MP0000689_abnormal_spleen_morphology | 0.78719873 |
| 121 | MP0003011_delayed_dark_adaptation | 0.77543740 |
| 122 | MP0005390_skeleton_phenotype | 0.77118177 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.77074295 |
| 124 | MP0004883_abnormal_blood_vessel | 0.76230564 |
| 125 | MP0002429_abnormal_blood_cell | 0.73670636 |
| 126 | MP0003795_abnormal_bone_structure | 0.71926204 |
| 127 | MP0003633_abnormal_nervous_system | 0.68806976 |
| 128 | MP0002398_abnormal_bone_marrow | 0.67346715 |
| 129 | MP0000490_abnormal_crypts_of | 0.65403353 |
| 130 | MP0000371_diluted_coat_color | 0.60453796 |
| 131 | MP0002722_abnormal_immune_system | 0.59931494 |
| 132 | MP0005647_abnormal_sex_gland | 0.56593002 |
| 133 | MP0005595_abnormal_vascular_smooth | 0.56370750 |
| 134 | MP0003091_abnormal_cell_migration | 0.55271534 |
| 135 | MP0000249_abnormal_blood_vessel | 0.54419494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Disinhibition (HP:0000734) | 5.57179450 |
| 2 | Mutism (HP:0002300) | 4.82247771 |
| 3 | * Vacuolated lymphocytes (HP:0001922) | 4.61669210 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.10628320 |
| 5 | Nuclear cataract (HP:0100018) | 3.82321866 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.75686915 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.60580523 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.55992197 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.51913114 |
| 10 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.50518310 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.35406043 |
| 12 | * Dysostosis multiplex (HP:0000943) | 3.33499273 |
| 13 | Apathy (HP:0000741) | 3.29389860 |
| 14 | Agnosia (HP:0010524) | 3.28966434 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.25863964 |
| 16 | Diminished motivation (HP:0000745) | 3.22635682 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.19432752 |
| 18 | Inappropriate behavior (HP:0000719) | 3.18149343 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.13951525 |
| 20 | Retinal atrophy (HP:0001105) | 3.09328689 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.09265076 |
| 22 | Glomerulonephritis (HP:0000099) | 3.07528608 |
| 23 | Xanthomatosis (HP:0000991) | 3.05093808 |
| 24 | Neuronal loss in central nervous system (HP:0002529) | 3.03290467 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.02883509 |
| 26 | Complement deficiency (HP:0004431) | 2.98523486 |
| 27 | Upper motor neuron abnormality (HP:0002127) | 2.97795642 |
| 28 | * Mucopolysacchariduria (HP:0008155) | 2.92752431 |
| 29 | * Urinary glycosaminoglycan excretion (HP:0003541) | 2.92752431 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.88651076 |
| 31 | Cerebral inclusion bodies (HP:0100314) | 2.88335143 |
| 32 | Progressive neurologic deterioration (HP:0002344) | 2.87846369 |
| 33 | Hematochezia (HP:0002573) | 2.85838045 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.81169231 |
| 35 | Hydroxyprolinuria (HP:0003080) | 2.80281323 |
| 36 | Abnormality of proline metabolism (HP:0010907) | 2.80281323 |
| 37 | Axonal loss (HP:0003447) | 2.74953642 |
| 38 | Hyperactive renin-angiotensin system (HP:0000841) | 2.74226317 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.73400053 |
| 40 | Vascular calcification (HP:0004934) | 2.71784487 |
| 41 | Intrahepatic cholestasis (HP:0001406) | 2.70723880 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.67549365 |
| 43 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.67083450 |
| 44 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.67083450 |
| 45 | * Abnormality of polysaccharide metabolism (HP:0011012) | 2.67083450 |
| 46 | Personality changes (HP:0000751) | 2.66823524 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.66203554 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.66045308 |
| 49 | Optic neuritis (HP:0100653) | 2.66045308 |
| 50 | Hyperglycinuria (HP:0003108) | 2.64799433 |
| 51 | Myocardial infarction (HP:0001658) | 2.63474157 |
| 52 | Metaphyseal irregularity (HP:0003025) | 2.63300909 |
| 53 | Stomatitis (HP:0010280) | 2.62807457 |
| 54 | Abnormality of complement system (HP:0005339) | 2.61598352 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.59468707 |
| 56 | Joint hemorrhage (HP:0005261) | 2.59281436 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.54234568 |
| 58 | Increased serum ferritin (HP:0003281) | 2.51672290 |
| 59 | Dementia (HP:0000726) | 2.48249085 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.48197450 |
| 61 | Deep venous thrombosis (HP:0002625) | 2.46139459 |
| 62 | Prolonged neonatal jaundice (HP:0006579) | 2.41485249 |
| 63 | Fat malabsorption (HP:0002630) | 2.40720626 |
| 64 | * Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.39806844 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.38621544 |
| 66 | Nephritis (HP:0000123) | 2.37388162 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31744238 |
| 68 | Obstructive lung disease (HP:0006536) | 2.31744238 |
| 69 | Prolonged partial thromboplastin time (HP:0003645) | 2.31076543 |
| 70 | Hyperammonemia (HP:0001987) | 2.30570558 |
| 71 | Global brain atrophy (HP:0002283) | 2.27481087 |
| 72 | Peripheral demyelination (HP:0011096) | 2.24712452 |
| 73 | Alkalosis (HP:0001948) | 2.23575133 |
| 74 | Metabolic alkalosis (HP:0200114) | 2.23180550 |
| 75 | Loss of speech (HP:0002371) | 2.22299831 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 2.21465325 |
| 77 | Glycosuria (HP:0003076) | 2.21465325 |
| 78 | Pathologic fracture (HP:0002756) | 2.19957042 |
| 79 | Asymmetric septal hypertrophy (HP:0001670) | 2.19821517 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.19319973 |
| 81 | Pustule (HP:0200039) | 2.18815079 |
| 82 | Conjunctival telangiectasia (HP:0000524) | 2.18471281 |
| 83 | Proximal tubulopathy (HP:0000114) | 2.17474144 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.16033629 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 2.15646944 |
| 86 | Abnormality of glycine metabolism (HP:0010895) | 2.15421220 |
| 87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15421220 |
| 88 | * Abnormality of chloride homeostasis (HP:0011422) | 2.15062520 |
| 89 | Steatorrhea (HP:0002570) | 2.14124943 |
| 90 | Amyloidosis (HP:0011034) | 2.13460899 |
| 91 | Esophageal varix (HP:0002040) | 2.12871466 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11685059 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11685059 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11685059 |
| 95 | Pancreatitis (HP:0001733) | 2.11041388 |
| 96 | Urticaria (HP:0001025) | 2.10580091 |
| 97 | Increased CSF protein (HP:0002922) | 2.10259543 |
| 98 | Ketosis (HP:0001946) | 2.08940798 |
| 99 | Abnormality of the common coagulation pathway (HP:0010990) | 2.08432093 |
| 100 | Recurrent skin infections (HP:0001581) | 2.06572206 |
| 101 | Multiple enchondromatosis (HP:0005701) | 2.06483762 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 2.05947902 |
| 103 | Hypokalemic alkalosis (HP:0001949) | 2.05294255 |
| 104 | Abnormality of the periventricular white matter (HP:0002518) | 2.05259283 |
| 105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04797217 |
| 106 | Nausea (HP:0002018) | 2.04796847 |
| 107 | Gingivitis (HP:0000230) | 2.04760976 |
| 108 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03659276 |
| 109 | Abnormality of nucleobase metabolism (HP:0010932) | 2.01094695 |
| 110 | Purpura (HP:0000979) | 1.99822437 |
| 111 | Hypoglycemic coma (HP:0001325) | 1.99522450 |
| 112 | Progressive visual loss (HP:0000529) | 1.99343833 |
| 113 | Memory impairment (HP:0002354) | 1.97487495 |
| 114 | Thoracic kyphosis (HP:0002942) | 1.97265454 |
| 115 | Supranuclear gaze palsy (HP:0000605) | 1.97123575 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.96982170 |
| 117 | Petechiae (HP:0000967) | 1.96102193 |
| 118 | Bone pain (HP:0002653) | 1.95703895 |
| 119 | Malnutrition (HP:0004395) | 1.94404233 |
| 120 | Gingival bleeding (HP:0000225) | 1.93781347 |
| 121 | Myositis (HP:0100614) | 1.93332784 |
| 122 | Gout (HP:0001997) | 1.91392448 |
| 123 | Vertebral compression fractures (HP:0002953) | 1.90520264 |
| 124 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.90138090 |
| 125 | Protuberant abdomen (HP:0001538) | 1.88488244 |
| 126 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88256807 |
| 127 | Periodontitis (HP:0000704) | 1.88211084 |
| 128 | Tetraparesis (HP:0002273) | 1.87308708 |
| 129 | Abdominal distention (HP:0003270) | 1.84435047 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84160118 |
| 131 | Abnormality of renal excretion (HP:0011036) | 1.84144935 |
| 132 | Ketoacidosis (HP:0001993) | 1.84066195 |
| 133 | Menorrhagia (HP:0000132) | 1.82342921 |
| 134 | Hypobetalipoproteinemia (HP:0003563) | 1.81627024 |
| 135 | Dicarboxylic aciduria (HP:0003215) | 1.81317020 |
| 136 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81317020 |
| 137 | Abnormality of magnesium homeostasis (HP:0004921) | 1.80758692 |
| 138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.80137628 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.80013075 |
| 140 | Orchitis (HP:0100796) | 1.79751585 |
| 141 | Urinary incontinence (HP:0000020) | 1.79188781 |
| 142 | * Polyneuropathy (HP:0001271) | 1.78620564 |
| 143 | Hypomagnesemia (HP:0002917) | 1.77890359 |
| 144 | Ileus (HP:0002595) | 1.76359989 |
| 145 | Abnormal tarsal ossification (HP:0008369) | 1.76290524 |
| 146 | Hemoptysis (HP:0002105) | 1.75883450 |
| 147 | Sensorimotor neuropathy (HP:0007141) | 1.75730109 |
| 148 | Keratoconjunctivitis sicca (HP:0001097) | 1.74371420 |
| 149 | Mucosal telangiectasiae (HP:0100579) | 1.72314124 |
| 150 | * Cardiomegaly (HP:0001640) | 1.72126770 |
| 151 | Abnormality of the basal ganglia (HP:0002134) | 1.70680075 |
| 152 | Abnormality of the nasal mucosa (HP:0000433) | 1.68519118 |
| 153 | Restrictive lung disease (HP:0002091) | 1.66868337 |
| 154 | J-shaped sella turcica (HP:0002680) | 1.63254884 |
| 155 | T lymphocytopenia (HP:0005403) | 1.62828914 |
| 156 | Vasculitis (HP:0002633) | 1.61186234 |
| 157 | Zonular cataract (HP:0010920) | 1.60667226 |
| 158 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.59494379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.19574984 |
| 2 | GRK7 | 3.38498413 |
| 3 | ACVR1B | 3.10842111 |
| 4 | MST4 | 3.04865543 |
| 5 | TAOK3 | 3.01208078 |
| 6 | DDR2 | 2.95961066 |
| 7 | BLK | 2.71888563 |
| 8 | TBK1 | 2.57453609 |
| 9 | TAOK2 | 2.54380601 |
| 10 | BCKDK | 2.54025533 |
| 11 | MST1R | 2.23537305 |
| 12 | TGFBR2 | 2.19573443 |
| 13 | MAP3K14 | 2.17045517 |
| 14 | IRAK3 | 2.14481064 |
| 15 | FGR | 2.13541577 |
| 16 | TYK2 | 2.10788301 |
| 17 | TAOK1 | 2.05504493 |
| 18 | MAP4K1 | 1.94186367 |
| 19 | PRPF4B | 1.89569526 |
| 20 | PIM2 | 1.87968570 |
| 21 | NME2 | 1.85801946 |
| 22 | CAMKK2 | 1.82298733 |
| 23 | IRAK4 | 1.72383011 |
| 24 | EPHB1 | 1.72140388 |
| 25 | IKBKE | 1.66794149 |
| 26 | NEK9 | 1.66588225 |
| 27 | PBK | 1.57532566 |
| 28 | IKBKB | 1.53953622 |
| 29 | KIT | 1.50422275 |
| 30 | LRRK2 | 1.49984878 |
| 31 | ADRBK2 | 1.49834407 |
| 32 | FGFR4 | 1.47671519 |
| 33 | PIK3CG | 1.47367233 |
| 34 | JAK3 | 1.45034345 |
| 35 | LMTK2 | 1.40554971 |
| 36 | WNK4 | 1.38349194 |
| 37 | CDC42BPA | 1.36630056 |
| 38 | RIPK4 | 1.35552109 |
| 39 | TESK1 | 1.33551805 |
| 40 | TRIB3 | 1.32609131 |
| 41 | SIK1 | 1.32033059 |
| 42 | EPHA3 | 1.30399213 |
| 43 | FRK | 1.26965118 |
| 44 | MOS | 1.26126815 |
| 45 | KDR | 1.25809815 |
| 46 | ZAP70 | 1.25187627 |
| 47 | JAK1 | 1.23660097 |
| 48 | STK39 | 1.23533896 |
| 49 | CSK | 1.22978467 |
| 50 | BTK | 1.22789265 |
| 51 | MAP3K3 | 1.21735122 |
| 52 | MYLK | 1.20813529 |
| 53 | OXSR1 | 1.18897825 |
| 54 | BMPR2 | 1.17980254 |
| 55 | MAP2K2 | 1.17831570 |
| 56 | STK10 | 1.15020621 |
| 57 | TESK2 | 1.12022542 |
| 58 | PTK6 | 1.08165634 |
| 59 | CSF1R | 1.05440331 |
| 60 | MAP2K3 | 1.04521898 |
| 61 | ABL2 | 1.02505294 |
| 62 | FLT3 | 1.01221610 |
| 63 | TEC | 1.00521981 |
| 64 | EPHB2 | 0.98816884 |
| 65 | PRKG2 | 0.94391062 |
| 66 | MAP3K11 | 0.94217461 |
| 67 | TGFBR1 | 0.93214333 |
| 68 | EPHA2 | 0.91950368 |
| 69 | MAP3K5 | 0.91043023 |
| 70 | NLK | 0.84283602 |
| 71 | DAPK2 | 0.83436528 |
| 72 | JAK2 | 0.82967647 |
| 73 | DYRK1B | 0.78974375 |
| 74 | LYN | 0.76450462 |
| 75 | FES | 0.76421426 |
| 76 | CHUK | 0.76107552 |
| 77 | MARK3 | 0.75929819 |
| 78 | GRK6 | 0.75826978 |
| 79 | PKN2 | 0.75467799 |
| 80 | IRAK1 | 0.74286572 |
| 81 | MATK | 0.72867431 |
| 82 | SYK | 0.68636903 |
| 83 | TYRO3 | 0.68168058 |
| 84 | MET | 0.68156577 |
| 85 | TRPM7 | 0.66645503 |
| 86 | SIK3 | 0.65221199 |
| 87 | PIM1 | 0.64051281 |
| 88 | HCK | 0.64021151 |
| 89 | LCK | 0.63592762 |
| 90 | NUAK1 | 0.63325400 |
| 91 | RIPK1 | 0.62235178 |
| 92 | CAMK1G | 0.62022481 |
| 93 | PAK4 | 0.61391745 |
| 94 | ITK | 0.59611702 |
| 95 | CAMK1D | 0.56554237 |
| 96 | PRKCD | 0.55327557 |
| 97 | ARAF | 0.54768235 |
| 98 | TXK | 0.53807862 |
| 99 | GRK1 | 0.53654715 |
| 100 | MAPK15 | 0.53607355 |
| 101 | PDGFRA | 0.53318910 |
| 102 | INSRR | 0.52381795 |
| 103 | RPS6KA4 | 0.49489604 |
| 104 | PIK3CA | 0.49211606 |
| 105 | PDPK1 | 0.47169021 |
| 106 | ABL1 | 0.46939166 |
| 107 | BMX | 0.46736676 |
| 108 | ICK | 0.46158133 |
| 109 | RPS6KC1 | 0.44829281 |
| 110 | RPS6KL1 | 0.44829281 |
| 111 | MAP3K13 | 0.42496045 |
| 112 | IRAK2 | 0.41097628 |
| 113 | LIMK1 | 0.40891471 |
| 114 | MAPK4 | 0.40282970 |
| 115 | CAMKK1 | 0.40139287 |
| 116 | MAP3K1 | 0.38439500 |
| 117 | MAPKAPK3 | 0.38353214 |
| 118 | MAP2K6 | 0.38129395 |
| 119 | RPS6KA2 | 0.37848925 |
| 120 | DAPK3 | 0.36848340 |
| 121 | PDK2 | 0.36082592 |
| 122 | PTK2 | 0.35684016 |
| 123 | PRKCQ | 0.35497423 |
| 124 | PDK1 | 0.33229336 |
| 125 | TIE1 | 0.33204604 |
| 126 | RPS6KA6 | 0.33142338 |
| 127 | CDK6 | 0.32836149 |
| 128 | EIF2AK3 | 0.31979033 |
| 129 | GSK3A | 0.31627371 |
| 130 | IGF1R | 0.31340731 |
| 131 | EGFR | 0.30865195 |
| 132 | MAPK11 | 0.30129232 |
| 133 | MAPK7 | 0.27406791 |
| 134 | TNK2 | 0.26920837 |
| 135 | CDK4 | 0.23213648 |
| 136 | KSR1 | 0.22493795 |
| 137 | INSR | 0.19590532 |
| 138 | FYN | 0.18854351 |
| 139 | CLK1 | 0.18258457 |
| 140 | MAP3K8 | 0.17367672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.94734351 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93631489 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.70631654 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.48822908 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.47441522 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.22584668 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.15910561 |
| 8 | * Other glycan degradation_Homo sapiens_hsa00511 | 2.13526023 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.07146269 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.05702561 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00931576 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97684291 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96281495 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95167418 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89827947 |
| 16 | * Lysosome_Homo sapiens_hsa04142 | 1.89812623 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.79544599 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.76121020 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70733124 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62608521 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.61526429 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57998405 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57411219 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56786120 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56537223 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51883985 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48347171 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47150797 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45026677 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37994695 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37525300 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33177959 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31557629 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.30006604 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28670956 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27433134 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24697984 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23682945 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21718422 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.21663602 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18385890 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17042339 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14778823 |
| 44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14064568 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13307914 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.10806970 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08539533 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08091448 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.07667416 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06987702 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04927220 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 1.04567777 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.03598733 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01199269 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00992994 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00794098 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00513035 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00123425 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99728488 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98947125 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98826354 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97427158 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96067514 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.96059554 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 0.95593674 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94938558 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93254077 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91217673 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90304915 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85873655 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85308521 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85227877 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84871441 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84191791 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82881817 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82713642 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.82599010 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82295265 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82176632 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81394102 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80966228 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80906674 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.80853616 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79260920 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79092097 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78868445 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78805704 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77312006 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.77279584 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.76463544 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75630854 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.74749467 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74544872 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73354338 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.72690269 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72272198 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71881056 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67500617 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67137869 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.65972119 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63011815 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62473380 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62137026 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61141407 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.61125238 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60878297 |
| 107 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60100200 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58715973 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58703529 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58584333 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58476120 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58300185 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58234939 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57609163 |
| 115 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56408597 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55812981 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55196736 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.55061385 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.54269663 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50408357 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49518200 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.48990265 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48756325 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48637573 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48391071 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47702921 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47598372 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47114057 |
| 129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46812502 |
| 130 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.45755641 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45053889 |
| 132 | Apoptosis_Homo sapiens_hsa04210 | 0.44652945 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43947131 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43154092 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38860415 |
| 136 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.35521080 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.34384433 |
| 138 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30844633 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29845726 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27587590 |
| 141 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24714941 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24227393 |
| 143 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22421223 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21616033 |
| 145 | HTLV-I infection_Homo sapiens_hsa05166 | 0.15059625 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.13785949 |
| 147 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.13418813 |
| 148 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.11210528 |
| 149 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.08690613 |
| 150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08160891 |
| 151 | Insulin resistance_Homo sapiens_hsa04931 | 0.06658500 |

